Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 50090-4737

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-4737). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Divalproex Fig1)

Figure 1 (Divalproex Fig1)
A line graph comparing the percentage reduction in CPS rate for patients taking Divalproex Sodium Delayed-Release Tablets versus a placebo. The vertical axis shows improvement or worsening in CPS rate percentage, while the horizontal axis indicates the percentage of patients. The graph displays two curves, with the Divalproex Sodium line showing greater improvement than the placebo.*
FDA Label Image

Figure 2 (Divalproex Fig2)

Figure 2 (Divalproex Fig2)
A cumulative percentage plot comparing high dose versus low dose Divalproex sodium delayed-release tablets. The x-axis shows percentage of patients from 0 to 100, and the y-axis shows percent reduction in CPS rate ranging from -100% to 100%. The graph illustrates improvement or worsening in CPS rate among patients receiving different dose levels of Divalproex sodium extended-release tablets.*
FDA Label Image

Figure-3 (Divalproex Fig3)

Figure-3 (Divalproex Fig3)
A bar chart comparing the effects of placebo and Divalproex Sodium Extended-Release Tablets, showing higher values for Divalproex Sodium with a marked statistical significance (p=0.006). The chart highlights the measured outcome for Divalproex Sodium 500 mg extended-release tablets versus placebo.*
FDA Label Image

Structure (Divalproex Str)

Structure (Divalproex Str)
FDA Label Image

Label Image (Lbl500904737)

Label Image (Lbl500904737)
Label for Divalproex sodium 500 mg extended-release film-coated tablets by A-S Medication Solutions. Includes dosage and storage instructions, package NDC 50090-4737, and details such as single daily dosing and storage temperature guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.